<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
#f2 { font-family:ff1,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
#f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
#f4 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f5 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f6 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f7 { font-family:ff6,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f8 { font-family:ff7,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f9 { font-family:ff8,monospace; font-weight:bold; font-style:normal; }
@font-face { font-family: ff9; src: url("9.ttf"); }
#f10 { font-family:ff9,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff10; src: url("10.ttf"); }
#f11 { font-family:ff10,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff11; src: url("11.ttf"); }
#f12 { font-family:ff11,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page1.png">
<div class="txt" style="position:absolute; left:478px; top:72px;"><span id="f2" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">기업 </span><span id="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Note</span></div>
<div class="txt" style="position:absolute; left:497px; top:92px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2017.7.26</span></div>
<div class="txt" style="position:absolute; left:190px; top:161px;"><span id="f11" style="font-size:20px;vertical-align:baseline;color:rgba(0,160,198,1);">삼성바이오로직스(207940)</span></div>
<div class="txt" style="position:absolute; left:28px; top:192px;"><span id="f2" style="font-size:18px;vertical-align:baseline;color:rgba(0,0,0,1);">매수(유지)</span></div>
<div class="txt" style="position:absolute; left:190px; top:193px;"><span id="f12" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">잘 팔리는 베네팔리!</span></div>
<div class="txt" style="position:absolute; left:28px; top:223px;"><span id="f2" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">목표주가: 350,000원(유지)</span></div>
<div class="txt" style="position:absolute; left:28px; top:252px;"><span id="f5" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">Stock Data</span></div>
<div class="txt" style="position:absolute; left:28px; top:267px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">KOSPI(7/25)</span></div>
<div class="txt" style="position:absolute; left:157px; top:267px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2,440</span></div>
<div class="txt" style="position:absolute; left:28px; top:278px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주가(7/25)</span></div>
<div class="txt" style="position:absolute; left:149px; top:278px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">287,000</span></div>
<div class="txt" style="position:absolute; left:28px; top:290px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">시가총액(십억원)</span></div>
<div class="txt" style="position:absolute; left:153px; top:290px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">18,989</span></div>
<div class="txt" style="position:absolute; left:28px; top:301px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">발행주식수(백만)</span></div>
<div class="txt" style="position:absolute; left:166px; top:301px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">66</span></div>
<div class="txt" style="position:absolute; left:28px; top:313px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">52주 최고/최저가(원)</span></div>
<div class="txt" style="position:absolute; left:123px; top:313px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">297,000/142,000</span></div>
<div class="txt" style="position:absolute; left:28px; top:324px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">일평균거래대금(6개월, 백만원)</span></div>
<div class="txt" style="position:absolute; left:153px; top:324px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">63,594</span></div>
<div class="txt" style="position:absolute; left:28px; top:335px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">유동주식비율/외국인지분율(%)</span></div>
<div class="txt" style="position:absolute; left:149px; top:335px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">21.7/9.8</span></div>
<div class="txt" style="position:absolute; left:28px; top:347px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주요주주(%) 삼성물산 외 3 인</span></div>
<div class="txt" style="position:absolute; left:160px; top:347px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">75.1</span></div>
<div class="txt" style="position:absolute; left:28px; top:377px;"><span id="f5" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">주가상승률</span></div>
<div class="txt" style="position:absolute; left:28px; top:399px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">절대주가(%)</span></div>
<div class="txt" style="position:absolute; left:28px; top:409px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">상대주가(%p)</span></div>
<div class="txt" style="position:absolute; left:92px; top:389px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1개월</span></div>
<div class="txt" style="position:absolute; left:95px; top:399px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">15.3</span></div>
<div class="txt" style="position:absolute; left:95px; top:409px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">12.7</span></div>
<div class="txt" style="position:absolute; left:125px; top:389px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6개월</span></div>
<div class="txt" style="position:absolute; left:128px; top:399px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">85.2</span></div>
<div class="txt" style="position:absolute; left:128px; top:409px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">67.1</span></div>
<div class="txt" style="position:absolute; left:154px; top:389px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">12개월</span></div>
<div class="txt" style="position:absolute; left:164px; top:399px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.0</span></div>
<div class="txt" style="position:absolute; left:164px; top:409px;"><span id="f5" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">0.0</span></div>
<div class="txt" style="position:absolute; left:28px; top:427px;"><span id="f5" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">12MF PBR 추이</span></div>
<div class="txt" style="position:absolute; left:29px; top:444px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">6.0</span></div>
<div class="txt" style="position:absolute; left:46px; top:441px;"><span id="f8" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">(배)</span></div>
<div class="txt" style="position:absolute; left:29px; top:459px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">5.0</span></div>
<div class="txt" style="position:absolute; left:29px; top:473px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">4.0</span></div>
<div class="txt" style="position:absolute; left:75px; top:442px;"><span id="f8" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">12MF PBR (좌)</span></div>
<div class="txt" style="position:absolute; left:140px; top:441px;"><span id="f8" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">(천원)</span></div>
<div class="txt" style="position:absolute; left:166px; top:444px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">400</span></div>
<div class="txt" style="position:absolute; left:75px; top:451px;"><span id="f8" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스 주가 (우)</span></div>
<div class="txt" style="position:absolute; left:166px; top:455px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">350</span></div>
<div class="txt" style="position:absolute; left:166px; top:466px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">300</span></div>
<div class="txt" style="position:absolute; left:166px; top:477px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">250</span></div>
<div class="txt" style="position:absolute; left:29px; top:488px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">3.0</span></div>
<div class="txt" style="position:absolute; left:166px; top:488px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">200</span></div>
<div class="txt" style="position:absolute; left:166px; top:499px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">150</span></div>
<div class="txt" style="position:absolute; left:29px; top:503px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">2.0</span></div>
<div class="txt" style="position:absolute; left:166px; top:510px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:29px; top:517px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">1.0</span></div>
<div class="txt" style="position:absolute; left:166px; top:521px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">50</span></div>
<div class="txt" style="position:absolute; left:29px; top:532px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">0.0</span></div>
<div class="txt" style="position:absolute; left:166px; top:532px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:35px; top:537px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">Aug-14</span></div>
<div class="txt" style="position:absolute; left:75px; top:537px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">Aug-15</span></div>
<div class="txt" style="position:absolute; left:116px; top:537px;"><span id="f3" style="font-size:4px;vertical-align:baseline;color:rgba(0,0,0,1);">Aug-16</span></div>
<div class="txt" style="position:absolute; left:28px; top:546px;"><span id="f5" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: WISEfn 컨센서스</span></div>
<div class="txt" style="position:absolute; left:189px; top:228px;"><span id="f6" style="font-size:10px;vertical-align:baseline;color:rgba(0,160,198,1);">베네팔리도 램시마 못지 않게 잘 팔린다</span></div>
<div class="txt" style="position:absolute; left:189px; top:243px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">Enbrel의 바이오시밀러 베네팔리는 유럽에서 “first-mover advantage”를 누리며 판매호</span></div>
<div class="txt" style="position:absolute; left:189px; top:257px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">조를 나타내고 있는 것으로 파악된다. Biogen(바이오에피스의 유럽 파트너)의 2분기 실적</span></div>
<div class="txt" style="position:absolute; left:189px; top:272px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">발표(미국 현지시간 7월 25일 오전)에 따르면 베네팔리의 2분기 유럽 매출액은 1분기</span></div>
<div class="txt" style="position:absolute; left:189px; top:286px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">6,530만달러 대비 36% 증가한 8,870만달러로 나타났다. 베네팔리의 2016년 연간 매출액</span></div>
<div class="txt" style="position:absolute; left:189px; top:300px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">이 1억 60만달러였다는 점을 감안하면 매출액은 빠르게 증가하고 있다. 베네팔리의 2분기</span></div>
<div class="txt" style="position:absolute; left:189px; top:314px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">판매호조로 인해 삼성바이오로직스의 2분기 지분법손실(216억원)도 1분기(508억원) 대비</span></div>
<div class="txt" style="position:absolute; left:189px; top:328px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">크게 감소할 수 있었다. 2017년 베네팔리 매출은 전년 대비 네 배 가량 증가한 4억달러</span></div>
<div class="txt" style="position:absolute; left:189px; top:343px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">(4,400억원) 수준으로 전망한다. 2014년 출시된 셀트리온의 램시마가 유럽에서 2015년</span></div>
<div class="txt" style="position:absolute; left:189px; top:357px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2,500억원, 2016년 6,200억원의 매출을 달성했다는 점을 감안하면 베네팔리의 판매성적</span></div>
<div class="txt" style="position:absolute; left:189px; top:371px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">은 램시마에 비해 크게 뒤떨어지지 않는다는 판단이다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:399px;"><span id="f6" style="font-size:10px;vertical-align:baseline;color:rgba(0,160,198,1);">바이오시밀러, 앞으로도 보여줄 것이 많다!</span></div>
<div class="txt" style="position:absolute; left:189px; top:414px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">미국 현지시각 7월 24일 삼성바이오로직스는 현지 파트너사 Merck와 함께 Remicade의</span></div>
<div class="txt" style="position:absolute; left:189px; top:428px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오시밀러 렌플렉시스를 오리지네이터 대비 35% 저렴한 가격(100mg 바이알 당</span></div>
<div class="txt" style="position:absolute; left:189px; top:442px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">753.39달러)에 미국에서 조기출시한다고 밝혔다. 이 외에도 2018년 상반기경 Humira의</span></div>
<div class="txt" style="position:absolute; left:189px; top:456px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오시밀러 임랄디, Lantus의 바이오시밀러 루수두나, Herceptin의 바이오시밀러 SB3</span></div>
<div class="txt" style="position:absolute; left:189px; top:470px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">의 유럽출시가 잇달아 예정되어 있는 만큼 바이오시밀러 사업을 영위하고 있는 자회사 바</span></div>
<div class="txt" style="position:absolute; left:189px; top:485px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">이오에피스의 실적개선에 대한 기대감은 하반기로 갈수록 고조될 전망이다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:512px;"><span id="f6" style="font-size:10px;vertical-align:baseline;color:rgba(0,160,198,1);">바이오시밀러 시장개화로 자회사 바이오에피스의 가치가 부각될 전망</span></div>
<div class="txt" style="position:absolute; left:189px; top:527px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스에 대해 투자의견 매수, 목표주가 350,000원을 유지한다. 목표주가는</span></div>
<div class="txt" style="position:absolute; left:189px; top:541px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2017년~2023년의 free cash flow를 합산해 현재 가치로 할인한 후 자회사 지분가치(바</span></div>
<div class="txt" style="position:absolute; left:189px; top:556px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">이오에피스 2.56조원[5.12조원의 50.1%], Archizen Biotech 340억원[680억원의 50%])와</span></div>
<div class="txt" style="position:absolute; left:189px; top:570px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2017년 순현금과 콜옵션 행사금 6,106억원을 더해 산출했다. 목표주가의 2017년 PBR은</span></div>
<div class="txt" style="position:absolute; left:189px; top:584px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">6.5배로 현재 셀트리온의 valuation(2017F PBR 6.4배)과 유사한 수준이다. 바이오에피스</span></div>
<div class="txt" style="position:absolute; left:189px; top:598px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">는 유럽과 미국에서 각각 1개의 first-mover와 second-mover를 보유하고 있다. 또한</span></div>
<div class="txt" style="position:absolute; left:189px; top:612px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2018년에는 3개의 second-mover를 유럽에서 추가로 확보할 것이다. 셀트리온의 파이프</span></div>
<div class="txt" style="position:absolute; left:189px; top:627px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">라인과 시가총액을 고려하면 삼성바이오로직스의 주가에는 바이오에피스의 가치가 충분히</span></div>
<div class="txt" style="position:absolute; left:189px; top:641px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">반영되지 않았다고 생각한다. 2분기 마지막 영업적자를 뒤로하고 3분기부터 흑자기조를</span></div>
<div class="txt" style="position:absolute; left:189px; top:655px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">이어가는 한편 바이오시밀러 시장의 본격 개화로 바이오에피스에 대한 지분가치가 부각될</span></div>
<div class="txt" style="position:absolute; left:189px; top:669px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">것으로 예상돼 삼성바이오로직스에 대해 장기적 관점에서 매수를 권고한다.</span></div>
<div class="txt" style="position:absolute; left:29px; top:711px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">진홍국 </span><span id="f5" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">3276-6196</span></div>
<div class="txt" style="position:absolute; left:29px; top:723px;"><span id="f3" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">hg.jin@truefriend.com</span></div>
<div class="txt" style="position:absolute; left:29px; top:741px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">정은영 </span><span id="f5" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">3276-6239</span></div>
<div class="txt" style="position:absolute; left:29px; top:753px;"><span id="f3" style="font-size:8px;vertical-align:baseline;color:rgba(0,0,0,1);">eunice.jung@truefriend.com</span></div>
<div class="txt" style="position:absolute; left:228px; top:694px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">매출액 영업이익 순이익</span></div>
<div class="txt" style="position:absolute; left:336px; top:694px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">EPS 증감률 EBITDA PER </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">EV/EBITDA </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">PBR ROE DY</span></div>
<div class="txt" style="position:absolute; left:223px; top:706px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(십억원) (십억원) (십억원)</span></div>
<div class="txt" style="position:absolute; left:338px; top:706px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(원)</span></div>
<div class="txt" style="position:absolute; left:367px; top:706px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(%) (십억원)</span></div>
<div class="txt" style="position:absolute; left:428px; top:706px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(x)</span></div>
<div class="txt" style="position:absolute; left:457px; top:706px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(x) (x) (%) (%)</span></div>
<div class="txt" style="position:absolute; left:189px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2015A</span></div>
<div class="txt" style="position:absolute; left:240px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">91</span></div>
<div class="txt" style="position:absolute; left:265px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(204) 1,905</span></div>
<div class="txt" style="position:absolute; left:345px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:368px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NM (162)</span></div>
<div class="txt" style="position:absolute; left:432px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:461px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:485px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">- 68.7</span></div>
<div class="txt" style="position:absolute; left:534px; top:717px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:189px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2016A</span></div>
<div class="txt" style="position:absolute; left:236px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">295</span></div>
<div class="txt" style="position:absolute; left:269px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(30)</span></div>
<div class="txt" style="position:absolute; left:300px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(177) (1,558)</span></div>
<div class="txt" style="position:absolute; left:368px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NM</span></div>
<div class="txt" style="position:absolute; left:402px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">30 NM 320.6 4.9 (5.2)</span></div>
<div class="txt" style="position:absolute; left:534px; top:728px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:189px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2017F</span></div>
<div class="txt" style="position:absolute; left:236px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">415</span></div>
<div class="txt" style="position:absolute; left:277px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">7</span></div>
<div class="txt" style="position:absolute; left:300px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(129) (1,954)</span></div>
<div class="txt" style="position:absolute; left:368px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NM</span></div>
<div class="txt" style="position:absolute; left:402px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">69 NM 274.5 5.3 (3.4)</span></div>
<div class="txt" style="position:absolute; left:534px; top:740px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:189px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2018F</span></div>
<div class="txt" style="position:absolute; left:236px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">573</span></div>
<div class="txt" style="position:absolute; left:270px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">110</span></div>
<div class="txt" style="position:absolute; left:304px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">497 1,487</span></div>
<div class="txt" style="position:absolute; left:368px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NM</span></div>
<div class="txt" style="position:absolute; left:399px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">185 193.0 100.6 4.7 13.1</span></div>
<div class="txt" style="position:absolute; left:534px; top:751px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
<div class="txt" style="position:absolute; left:189px; top:762px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2019F</span></div>
<div class="txt" style="position:absolute; left:236px; top:762px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">944</span></div>
<div class="txt" style="position:absolute; left:270px; top:762px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">330</span></div>
<div class="txt" style="position:absolute; left:304px; top:762px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">266 4,022 170.5</span></div>
<div class="txt" style="position:absolute; left:399px; top:762px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">436 71.4 42.1 4.7 6.6</span></div>
<div class="txt" style="position:absolute; left:534px; top:762px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">-</span></div>
</body>
</html>
